Web Stats Provided By Google Analytics

Saturday, October 14, 2017

CymaBay Therapeutics Inc. (CBAY) Sees Significant Increase in Short Interest

... Wace North America L.P. bought a new position in CymaBay Therapeutics during the 2nd quarter worth $242,000. Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners now owns 50,210 ...
http://ift.tt/2zmZenx

No comments:

Post a Comment

Popular Ardsley Roundup Posts